Research and Development

Showing 15 posts of 9084 posts found.


FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023 Research and Development FDA, Infections and infestations, Inflammatix, TriVerity, infection, sepsis

Inflammatix has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s lead …

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023 Research and Development FDA, Opioid overdose, Pharmacy, opioids, orexo

Orexo has announced that its New Drug Application (NDA) for OX124 has been accepted for review by the US Food …

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023 Research and Development Arcturus Therapeutics, Chronic Diseases, FDA, ODD, cystic fibrosis

Arcturus Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ARCT-032, …

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023 Research and Development Alladapt Immunotherapeutics, Allergic Disorders, FDA, fast track designation, food allergy

Alladapt Immunotherapeutics has announced that ADP101 has received Fast Track Designation from the US Food and Drug Administration (FDA) as …

MorphoSys shares phase 3 trial results for pelabresib in myelofibrosis treatment

November 23, 2023 Research and Development Haematology, clinical trial, morphosys, myelofibrosis, pelabresib

MorphoSys has announced topline results from its phase 3 MANIFEST-2 study, which assessed pelabresib, an investigational BET inhibitor, in combination …

Genentech and NVIDIA enter AI research collaboration

November 22, 2023 Research and Development AI, Genentech, Pharmacy, research collaboration

Genentech has announced that it has entered into a multi-year strategic research collaboration with NVIDIA that is intended to pair …

AstraZeneca’s Imfinzi meets primary endpoint for liver cancer treatment

November 13, 2023 Research and Development AstraZeneca, Imfinzi, Oncology, clinical trial, liver cancer

AstraZeneca has announced positive results from the EMERALD-1 phase 3 trial for Imfinzi (durvalumab) in combination with transarterial chemoembolisation (TACE) …

First patient dosed in AdvanCell’s phase 1/2 trial for prostate cancer treatment

November 9, 2023 Research and Development AdvanCell, Cancer, Oncology, clinical trial, prostate cancer

AdvanCell has announced that the first patient has been dosed with 212Pb-ADVC001 in its phase 1/2 trial for the PSMA-positive …

J&J’s to submit surgical robot to FDA in 2024

November 8, 2023 Research and Development FDA, J&J, Johnson & Johnson MedTech, Pharmacy, surgical robot

Johnson & Johnson MedTech have announced plans to submit the Ottava robotic surgical system to the US Food and Drug …

Evotec and Dewpoint Therapeutics enter strategic partnership

November 7, 2023 Research and Development Dewpoint Therapeutics, Evotec, Oncology, R&D, oncology

Evotec and Dewpoint Therapeutics have announced a strategic R&D collaboration for the advancement of Dewpoint’s oncology pipeline programmes of condensate …

AstraZeneca shares results from ZENITH-CKD phase 2b trial for chronic kidney disease and proteinuria treatment

November 6, 2023 Research and Development AstraZeneca, CKD, Nephrology, kidney disease, proteinuria

AstraZeneca has announced results from the ZENITH-CKD phase 2b clinical trial for the combination of zibotentan with dapagliflozin for the …

AstraZeneca and Cellectis to collaborate for cell therapy and genomic medicine development

November 1, 2023 Research and Development AstraZeneca, CGT, Pharmacy, cell therapy, cellectis, genomic medicine

AstraZeneca has announced a collaboration and investment agreement with Cellectis for the development of next generation cell and gene therapeutics …

First patient enrolled in Boan Biotech’s phase 3 trial for Nivolumab in China

October 30, 2023 Research and Development Boan Biotech, China, Oncology, clinical trial, nivolumab

Boan Biotech has announced that the first patient has been enrolled in its phase 3 trial of its Nivolumab injection …

China’s NMPA approves ViiV Healthcare’s Vocabria in combination with Rekambys for HIV treatment

October 26, 2023 Research and Development HIV, HIV/AIDS, NMPA, ViiV Healthcare, Vocabria

ViiV Healthcare has announced that the National Medical Products Administration (NMPA) of China has approved Vocabria (cabotegravir injection) used in …

Eisai shares new data for Leqembi for Alzheimer’s treatment

October 26, 2023 Research and Development Alzheimer's, Biogen, Eisai, Neurology, lecanemab

Eisai and Biogen have announced that Eisai has shared new data for Leqembi (lecanemab-irmb) 100mg/mL injection for intravenous (IV) use …

Latest content